Michael Fung‐Kee‐Fung

Author

Also Known As

M FUNGKEEFUNG, M Fung-Kee-Fung, M. FUNG-KEE-FUNG, M. Fung-Kee-Fung, Michael Fung-Kee-Fung, Michael FungKeeFung, Michael Fung‐Kee‐Fung

112

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Ottawa Ottawa Hospital Princess Margaret Cancer Centre University of Alberta Centre Hospitalier de l’Université de Montréal

About

Michael Fung‐Kee‐Fung is an author at University of Ottawa specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	607
2	Public Health	5	5	222
3	Health Sciences	2	2	38
4	Nursing	1	1	35
5	Anesthesia	1	1	18

Michael Fung‐Kee‐Fung

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer Michael Fung‐Kee‐Fung, Thomas R. Oliver, Laurie Elit, Current Oncology	2007	225
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm Joseph E. Tota, J. Bentley, Jennifer Blake, Preventive Medicine Molecular Hpv TestingCervical Cancer ManagementCervical Cancer ScreeningCervical CancerCervical Health	2017	113
Follow-Up for Women after Treatment for Cervical Cancer L. Elit, Anthony Fyles, Thomas K. Oliver, Current Oncology	2010	82
Architectural frameworks: defining the structures for implementing learning health systems Lysanne Lessard, Wojtek Michalowski, Michael Fung‐Kee‐Fung, Implementation Science	2017	71
Management of a Suspicious Adnexal Mass: A Clinical Practice Guideline Jason Dodge, Allan Covens, Christina Lacchetti, Current Oncology	2012	68
Regional Process Redesign of Lung Cancer Care: A Learning Health System Pilot Project Michael Fung‐Kee‐Fung, Donna E. Maziak, Jason Pantarotto, Current Oncology	2018	68
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer Diane Provencher, C. Gallagher, Wendy R. Parulekar, Annals of Oncology Optimal Debulking SurgeryGynecologic SurgerySurgical OncologyGynecological SurgeryNeoadjuvant Chemotherapy	2017	66
Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia Tien Le, Chantal Ménard, Wendy Hicks-Boucher, Gynecologic Oncology UrologyVulvar DiseasesGynecological SurgeryMedicineGynecology	2007	57
Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking Tien Le, Kathryn Williams, Mary K. Senterman, Gynecologic Oncology Surgical OncologyHistopathologic AssessmentNeoadjuvant ChemotherapyMedicineCancer Management	2007	53
Development of Communities of Practice to Facilitate Quality Improvement Initiatives in Surgical Oncology Michael Fung‐Kee‐Fung, Elena Goubanova, Karen Sequeira, Quality Management in Health Care	2008	52

Page 1